Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDSX NYSE:CORBF NASDAQ:DCGO NASDAQ:QIPT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDSXBiodesix$7.54-2.6%$8.12$3.44▼$34.40$55.27M0.98203,367 shs33,120 shsCORBFGlobal Cord Blood$0.75-25.0%$0.99$0.20▼$1.75$91.16M-0.682,536 shs363 shsDCGODocGo$1.24-2.4%$1.51$1.20▼$5.68$121.28M0.95793,664 shs3.39 million shsQIPTQuipt Home Medical$2.57-1.5%$2.46$1.35▼$3.27$111.65M0.6542,464 shs138,059 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDSXBiodesix0.00%-0.13%-12.32%+40.32%-77.10%CORBFGlobal Cord Blood0.00%0.00%-4.76%+81.82%-42.86%DCGODocGo0.00%-7.30%-19.62%-16.45%-62.09%QIPTQuipt Home Medical0.00%-2.61%+0.77%+50.87%-6.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDSXBiodesix$7.54-2.6%$8.12$3.44▼$34.40$55.27M0.98203,367 shs33,120 shsCORBFGlobal Cord Blood$0.75-25.0%$0.99$0.20▼$1.75$91.16M-0.682,536 shs363 shsDCGODocGo$1.24-2.4%$1.51$1.20▼$5.68$121.28M0.95793,664 shs3.39 million shsQIPTQuipt Home Medical$2.57-1.5%$2.46$1.35▼$3.27$111.65M0.6542,464 shs138,059 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDSXBiodesix0.00%-0.13%-12.32%+40.32%-77.10%CORBFGlobal Cord Blood0.00%0.00%-4.76%+81.82%-42.86%DCGODocGo0.00%-7.30%-19.62%-16.45%-62.09%QIPTQuipt Home Medical0.00%-2.61%+0.77%+50.87%-6.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDSXBiodesix 2.50Moderate Buy$32.50331.03% UpsideCORBFGlobal Cord Blood 0.00N/AN/AN/ADCGODocGo 2.17Hold$3.24161.09% UpsideQIPTQuipt Home Medical 2.00Hold$3.1522.57% UpsideCurrent Analyst Ratings BreakdownLatest BDSX, DCGO, CORBF, and QIPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025BDSXBiodesixWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025DCGODocGoWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025QIPTQuipt Home MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/19/2025BDSXBiodesixCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$30.00 ➝ $20.008/21/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$1.45 ➝ $1.608/19/2025QIPTQuipt Home MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$1.70 ➝ $2.30(Data available from 10/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDSXBiodesix$71.32M0.77N/AN/A$2.87 per share2.63CORBFGlobal Cord Blood$196.12M0.46$0.54 per share1.40N/A∞DCGODocGo$435.97M0.28$0.41 per share3.00$3.09 per share0.40QIPTQuipt Home Medical$238.38M0.47$1.00 per share2.57$2.49 per share1.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDSXBiodesix-$42.93M-$5.80N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)CORBFGlobal Cord Blood$79.04MN/A0.00∞N/AN/AN/AN/AN/ADCGODocGo$19.99M-$0.19N/A15.50N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)QIPTQuipt Home Medical-$6.76M-$0.24N/AN/AN/A-4.30%-9.78%-4.23%12/15/2025 (Estimated)Latest BDSX, DCGO, CORBF, and QIPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q3 2025QIPTQuipt Home Medical$0.03-$0.07-$0.10-$0.07$80.37 million$58.30 million8/7/2025Q2 2025BDSXBiodesix-$1.40-$1.60-$0.20-$0.08$18.47 million$20.02 million8/7/2025Q2 2025DCGODocGo-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBDSXBiodesixN/AN/AN/AN/AN/ACORBFGlobal Cord BloodN/AN/AN/AN/AN/ADCGODocGoN/AN/AN/AN/AN/AQIPTQuipt Home MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDSXBiodesix41.112.142.14CORBFGlobal Cord BloodN/AN/AN/ADCGODocGoN/A2.362.36QIPTQuipt Home Medical0.711.150.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDSXBiodesix20.96%CORBFGlobal Cord BloodN/ADCGODocGo56.44%QIPTQuipt Home Medical42.85%Insider OwnershipCompanyInsider OwnershipBDSXBiodesix30.10%CORBFGlobal Cord Blood0.50%DCGODocGo3.80%QIPTQuipt Home Medical13.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDSXBiodesix2207.33 million5.13 millionOptionableCORBFGlobal Cord Blood1,200121.55 millionN/ANot OptionableDCGODocGo4,40797.81 million94.09 millionOptionableQIPTQuipt Home Medical1,20043.44 million37.62 millionOptionableBDSX, DCGO, CORBF, and QIPT HeadlinesRecent News About These CompaniesAll You Need to Know About Quipt Home Medical (QIPT) Rating Upgrade to BuySeptember 25, 2025 | zacks.comQuipt Home Medical Corp. $QIPT Shares Sold by Kanen Wealth Management LLCSeptember 23, 2025 | marketbeat.com194,100 Shares in Quipt Home Medical Corp. $QIPT Purchased by Strs OhioSeptember 23, 2025 | marketbeat.comNuveen Takes Stake in Quipt Home Medical Corp. (QIPT)September 22, 2025 | finance.yahoo.comNuveen Takes Stake in Quipt Home Medical Corp. (QIPT)September 21, 2025 | insidermonkey.comForager’s 120% Premium for Quipt Would Set M&A Benchmark; Board’s Inaction Erodes Shareholder IRRSeptember 10, 2025 | markets.businessinsider.comForager says ‘committed’ to pursuing Quipt Home Medical transactionSeptember 10, 2025 | msn.com150,046 Shares in Quipt Home Medical Corp. $QIPT Purchased by Nuveen LLCSeptember 8, 2025 | marketbeat.comQuipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in RevenueSeptember 3, 2025 | financialpost.comFQuipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in RevenueSeptember 3, 2025 | globenewswire.comQuipt Home Medical Confirms Receipt of Forager’s Repetitive Undervalued Offer; Board Denounces Inferior Terms and Self-Serving TacticsAugust 27, 2025 | financialpost.comFForager Capital submits proposal to acquire Quipt for $3.10 per share in cashAugust 25, 2025 | msn.comQuipt Home Medical stock soars after $3.10 per share acquisition offerAugust 25, 2025 | finance.yahoo.comIs Quipt Home Medical stock a buy?August 18, 2025 | cantechletter.comCQuipt Home Medical Corp. (QIPT) Q3 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comQuipt Home Medical Partners With Three Major Health Systems to Form Strategic Joint VentureAugust 12, 2025 | globenewswire.comQuipt Home Medical Reports Improved Fiscal Third Quarter 2025 ResultsAugust 11, 2025 | financialpost.comFQuipt Home Medical Reports Improved Fiscal Third Quarter 2025 ResultsAugust 11, 2025 | globenewswire.comQuipt Home Medical to Release Q3 2025 Financial ResultsJuly 29, 2025 | tipranks.comQuipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025July 29, 2025 | financialpost.comFQuipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025July 29, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDSX, DCGO, CORBF, and QIPT Company DescriptionsBiodesix NASDAQ:BDSX$7.54 -0.20 (-2.58%) Closing price 04:00 PM EasternExtended Trading$7.62 +0.09 (+1.13%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.Global Cord Blood NYSE:CORBF$0.75 -0.25 (-25.00%) As of 10:30 AM EasternGlobal Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.DocGo NASDAQ:DCGO$1.24 -0.03 (-2.36%) Closing price 04:00 PM EasternExtended Trading$1.25 +0.01 (+0.40%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Quipt Home Medical NASDAQ:QIPT$2.57 -0.04 (-1.53%) Closing price 04:00 PM EasternExtended Trading$2.56 0.00 (-0.19%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Insiders Buy Shares—Should Investors Follow Suit? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught? Starbucks Stock Slumps; This Competitor Shows Strength Broadcom’s VMware Push Takes Aim at Microsoft, Google, & Amazon Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
